Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) vs daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma

被引：0

作者：

Tan, Carlyn Rose ^{[1
]}

Maclachlan, Kylee ^{[2
]}

Nemirovsky, David ^{[3
]}

Derkach, Andriy ^{[1
]}

Hultcrantz, Malin ^{[2
]}

Hassoun, Hani ^{[2
]}

Mailankody, Sham ^{[2
]}

Shah, Urvi ^{[2
]}

Patel, Dhwani ^{[1
]}

Shekarkhand, Tala ^{[1
]}

Rueda, Colin ^{[1
]}

Lahoud, Oscar ^{[1
]}

Shah, Gunjan ^{[1
]}

Scordo, Michael ^{[1
]}

Chung, David ^{[4
]}

Landau, Heather ^{[4
]}

Giralt, Sergio ^{[1
]}

Usmani, Saad ^{[1
]}

Lesokhin, Alexander ^{[1
]}

Korde, Neha ^{[2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant & Cellular Therapy, New York, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P166

引用

页码：S127 / S127

页数：1

共 50 条

[21] A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Sonneveld, Pieter
Dimopoulos, Meletios A.
Boccadoro, Mario
Quach, Hang
Ho, P. Joy
Beksac, Meral
Hulin, Cyrille
Antonioli, Elisabetta
Leleu, Xavier
Mangiacavalli, Silvia
Perrot, Aurore
Cavo, Michele
Belotti, Angelo
Broijl, Annemiek
Gay, Francesca
Mina, Roberto
van de Donk, Niels W. C. J.
Katodritou, Eirini
Schjesvold, Fredrik
Balari, Anna Sureda
Rosinol, Laura
Delforge, Michel
Roeloffzen, Wilfried
Silzle, Tobias
Vangsted, Annette
Einsele, Hermann
Spencer, Andrew
Hajek, Roman
Jurczyszyn, Artur
Lonergan, Sarah
Ahmadi, Tahamtan
Liu, Yanfang
Wang, Jianping
Vieyra, Diego
van Brummelen, Emilie M. J.
Vanquickelberghe, Veronique
Sitthi-Amorn, Anna
de Boer, Carla J.
Carson, Robin
Rodriguez-Otero, Paula
Blade, Joan
Moreau, Philippe
FUTURE ONCOLOGY, 2024, 20 (38) : 3043 - 3063
[22] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Ajay K. Nooka
Jonathan L. Kaufman
Cesar Rodriguez
Andrzej Jakubowiak
Yvonne Efebera
Brandi Reeves
Tanya Wildes
Sarah A. Holstein
Larry D. Anderson
Ashraf Badros
Leyla Shune
Ajai Chari
Huiling Pei
Annelore Cortoos
Sharmila Patel
J. Blake Bartlett
Jessica Vermeulen
Thomas S. Lin
Paul G. Richardson
Peter Voorhees
Blood Cancer Journal, 12
[23] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Nooka, Ajay K.
Kaufman, Jonathan L.
Rodriguez, Cesar
Jakubowiak, Andrzej
Efebera, Yvonne
Reeves, Brandi
Wildes, Tanya
Holstein, Sarah A.
Anderson, Larry D., Jr.
Badros, Ashraf
Shune, Leyla
Chari, Ajai
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Richardson, Paul G.
Voorhees, Peter
BLOOD CANCER JOURNAL, 2022, 12 (04)
[24] Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
Sborov, Douglas W.
Baljevic, Muhamed
Reeves, Brandi
Laubach, Jacob
Efebera, Yvonne A.
Rodriguez, Cesar
Costa, Luciano J.
Chari, Ajai
Silbermann, Rebecca
Holstein, Sarah A.
Anderson, Larry D., Jr.
Kaufman, Jonathan L.
Shah, Nina
Pei, Huiling
Patel, Sharmila
Cortoos, Annelore
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Voorhees, Peter M.
Richardson, Paul G.
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 355 - 365
[25] Phase 2 Trial of Ixazomib, Lenalidomide, Dexamethasone and Daratumumab in Patients with Newly Diagnosed Multiple Myeloma
Kumar, Shaji K.
Kapoor, Prashant
Laplant, Betsy
Muchtar, Eli
Buadi, Francis K.
Gonsalves, Wilson I.
Dingli, David
Go, Ronald S.
Warsame, Rahma
Kourelis, Taxiarchis
Lust, John A.
Lacy, Martha Q.
Dispenzieri, Angela
Hayman, Suzanne R.
Hwa, Yi
Fonder, Amie
Hobbs, Miriam
Leung, Nelson
Rajkumar, S. Vincent
Gertz, Morie A.
Wolfe, Eric
BLOOD, 2018, 132
[26] Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
McCaughan, Georgia J.
Gandolfi, Sara
Moore, John J.
Richardson, Paul G.
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 190 - 204
[27] Daratumumab, carfilzomib, fi lzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma
Touzeau, Cyrille
Perrot, Aurore
Hulin, Cyrille
Manier, Salomon
Macro, Margaret
Chretien, Marie-Lorraine
Karlin, Lionel
Escoffre, Martine
Jacquet, Caroline
Tiab, Mourad
Leleu, Xavier
Avet-Loiseau, Herve
Jobert, Alexandra
Planche, Lucie
Corre, Jill
Moreau, Philippe
BLOOD, 2024, 143 (20) : 2029 - 2036
[28] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Richardson, Paul G.
Weller, Edie
Lonial, Sagar
Jakubowiak, Andrzej J.
Jagannath, Sundar
Raje, Noopur S.
Avigan, David E.
Xie, Wanling
Ghobrial, Irene M.
Schlossman, Robert L.
Mazumder, Amitabha
Munshi, Nikhil C.
Vesole, David H.
Joyce, Robin
Kaufman, Jonathan L.
Doss, Deborah
Warren, Diane L.
Lunde, Laura E.
Kaster, Sarah
DeLaney, Carol
Hideshima, Teru
Mitsiades, Constantine S.
Knight, Robert
Esseltine, Dixie-Lee
Anderson, Kenneth C.
BLOOD, 2010, 116 (05) : 679 - 686
[29] Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone plus /- daratumumab induction regimen
Meseha, Mina
Abusamra, Murad
Farooki, Azeez
Derkach, Andriy
Maclachlan, Kylee
Hultcrantz, Malin
Hassoun, Hani
Shah, Urvi
Lu, Sydney
Mailankody, Sham
Patel, Dhwani
Lahoud, Oscar
Shah, Gunjan
Scordo, Michael
Chung, David
Landau, Heather
Lesokhin, Alexander
Korde, Neha
Giralt, Sergio
Usmani, Saad
Tan, Carlyn
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S139 - S140
[30] A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Khan, Meaghan L.
Reeder, Craig B.
Kumar, Shaji K.
Lacy, Marthy Q.
Reece, Donna E.
Dispenzieri, Angela
Gertz, Morie A.
Greipp, Phillip
Hayman, Suzanne
Zeldenhurst, Steven
Dingli, David
Lust, John
Russell, Stephen
Laumann, Kristina M.
Mikhael, Joseph R.
Bergsagel, P. Leif
Fonseca, Rafael
Rajkumar, S. Vincent
Stewart, A. Keith
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 326 - 333

← 1 2 3 4 5 →